Ciprofloxacin therapy in cystic fibrosis.

作者信息

Raeburn J A, Govan J R, McCrae W M, Greening A P, Collier P S, Hodson M E, Goodchild M C

机构信息

University of Edinburgh.

出版信息

J Antimicrob Chemother. 1987 Sep;20(3):295-6. doi: 10.1093/jac/20.3.295.

DOI:10.1093/jac/20.3.295

PMID:3680073

Abstract

摘要

相似文献

Ciprofloxacin therapy in cystic fibrosis.

J Antimicrob Chemother. 1987 Sep;20(3):295-6. doi: 10.1093/jac/20.3.295.

Ciprofloxacin in cystic fibrosis.

Lancet. 1986 May 10;1(8489):1103. doi: 10.1016/s0140-6736(86)91374-7.

Ciprofloxacin in the treatment of Pseudomonas infection in children with cystic fibrosis.

Diagn Microbiol Infect Dis. 1990 Mar-Apr;13(2):153-5. doi: 10.1016/0732-8893(90)90099-h.

Quality of well-being before and after antibiotic treatment of pulmonary exacerbation in patients with cystic fibrosis.

Chest. 1990 Nov;98(5):1081-4. doi: 10.1378/chest.98.5.1081.

Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.

Ther Adv Respir Dis. 2015 Dec;9(6):272-80. doi: 10.1177/1753465815601571. Epub 2015 Sep 4.

[Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].

Pediatr Med Chir. 1990 Sep-Oct;12(5):531-4.

Cystic fibrosis: intravenous treatment at home.

Nurs Times. 1989;85(12):40-2.

Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.

Chemotherapy. 1980;26(2):135-40. doi: 10.1159/000237895.

Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.

Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252.

[Making antibiotic therapy easier to use. A welcome advance for those with cystic fibrosis].

Perspect Infirm. 2011 Jul-Aug;8(4):54-5.

引用本文的文献

Cystic fibrosis--an Indian perspective on recent advances in diagnosis and management.

Indian J Pediatr. 1996 Mar-Apr;63(2):189-98. doi: 10.1007/BF02845243.

Safety and efficacy of ciprofloxacin in paediatric patients--review.

Infection. 1993 Nov-Dec;21(6):413-21. doi: 10.1007/BF01728929.

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.

Fluoroquinolone antimicrobial agents.

Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

Infection. 1989 Mar-Apr;17(2):65-9. doi: 10.1007/BF01646878.

Isolation of fluoroquinolone-resistant Escherichia coli and Klebsiella pneumoniae from an infected Hickman catheter.

Eur J Clin Microbiol Infect Dis. 1990 May;9(5):345-7. doi: 10.1007/BF01973741.

Development of resistance to ciprofloxacin in nutrient-rich and nutrient-limited growth conditions in vitro by Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Antimicrob Agents Chemother. 1991 Dec;35(12):2649-51. doi: 10.1128/AAC.35.12.2649.

In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.

Antimicrob Agents Chemother. 1992 Feb;36(2):255-61. doi: 10.1128/AAC.36.2.255.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验